Free Trial

vTv Therapeutics (VTVT) News Today

vTv Therapeutics logo
$21.45 -1.01 (-4.50%)
As of 03:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
vTv Therapeutics Inc. stock logo
vTv Therapeutics (VTVT) to Release Quarterly Earnings on Thursday
vTv Therapeutics (NASDAQ:VTVT) will be releasing earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-vtv-therapeutics-inc-stock/)
vTv Therapeutics Inc. stock logo
Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Expands By 42.2%
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 22,900 shares, a growth of 42.2% from the March 31st total of 16,100 shares. Based on an average trading volume of 22,000 shares, the short-interest ratio is presently 1.0 days. Currently, 1.6% of the company's stock are sold short.
vTv Therapeutics Inc. stock logo
vTv Therapeutics Inc. (NASDAQ:VTVT) Sees Significant Decrease in Short Interest
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 16,100 shares, a drop of 34.3% from the March 15th total of 24,500 shares. Based on an average daily volume of 22,400 shares, the short-interest ratio is currently 0.7 days. Approximately 1.1% of the company's stock are short sold.
vTv Therapeutics Inc. stock logo
vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of vTv Therapeutics in a research report on Wednesday. They issued a "sell" rating for the company.
vTv Therapeutics Inc. stock logo
What is HC Wainwright's Forecast for VTVT Q1 Earnings?
vTv Therapeutics Inc. (NASDAQ:VTVT - Free Report) - HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for vTv Therapeutics in a research report issued to clients and investors on Wednesday, April 9th. HC Wainwright analyst E. Bodnar expects that the biotechnology company will
vTv Therapeutics Inc. stock logo
HC Wainwright Begins Coverage on vTv Therapeutics (NASDAQ:VTVT)
HC Wainwright started coverage on vTv Therapeutics in a research note on Wednesday. They set a "buy" rating and a $36.00 price target on the stock.
vTv Therapeutics initiated with a Buy at H.C. Wainwright
vTv Therapeutics Inc. stock logo
vTv Therapeutics (NASDAQ:VTVT) Now Covered by StockNews.com
StockNews.com initiated coverage on vTv Therapeutics in a research note on Thursday. They set a "sell" rating for the company.
vTv Therapeutics Inc. stock logo
vTv Therapeutics (NASDAQ:VTVT) Issues Quarterly Earnings Results
vTv Therapeutics (NASDAQ:VTVT - Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.55) earnings per share for the quarter, topping analysts' consensus estimates of ($0.87) by $0.32.
vTv Therapeutics reports Q4 EPS (55c) vs ($1.67) last year
vTv Therapeutics Inc. stock logo
vTv Therapeutics Inc. (NASDAQ:VTVT) Sees Significant Decline in Short Interest
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) saw a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 24,100 shares, a decline of 13.6% from the February 13th total of 27,900 shares. Currently, 1.6% of the company's shares are short sold. Based on an average daily trading volume, of 13,300 shares, the days-to-cover ratio is currently 1.8 days.
vTv Therapeutics Inc. stock logo
StockNews.com Begins Coverage on vTv Therapeutics (NASDAQ:VTVT)
StockNews.com initiated coverage on shares of vTv Therapeutics in a report on Wednesday. They set a "sell" rating on the stock.
vTv Therapeutics stock surges on FDA update
vTv Therapeutics Inc. stock logo
vTv Therapeutics (VTVT) Projected to Post Quarterly Earnings on Tuesday
vTv Therapeutics (NASDAQ:VTVT) will be releasing earnings before the market opens on Tuesday, March 11, Financial Modeling Prep reports.
vTv Therapeutics CFO to Resign in March
vTv Therapeutics Inc. stock logo
vTv Therapeutics (NASDAQ:VTVT) Earns Sell Rating from Analysts at StockNews.com
StockNews.com began coverage on vTv Therapeutics in a report on Saturday. They issued a "sell" rating for the company.
vTv Therapeutics Inc. stock logo
vTv Therapeutics (NASDAQ:VTVT) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on vTv Therapeutics in a report on Wednesday. They set a "sell" rating for the company.
vTv Therapeutics Faces License Agreement Termination
Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?
5VT0.MU,0P0001EVLU,0 (5VT0.MU)
VTV THERAPEUT. A NEW O.N. (5VT0.BE)
Get vTv Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter.

VTVT Media Mentions By Week

VTVT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VTVT
News Sentiment

0.65

0.72

Average
Medical
News Sentiment

VTVT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VTVT Articles
This Week

3

1

VTVT Articles
Average Week

Get vTv Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VTVT) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners